PRINCIPLES OF KETO ACID THERAPY IN UREMIA

被引:14
作者
WALSER, M
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT EXPTL THERAPEUT, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA
关键词
D O I
10.1093/ajcn/31.10.1756
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
引用
收藏
页码:1756 / 1760
页数:5
相关论文
共 20 条
[1]   POSSIBLE REGULATOR OF PROTEIN TURNOVER IN MUSCLE [J].
BUSE, MG ;
REID, SS .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (05) :1250-1261
[2]  
FELIG P, 1975, CLIN RES, V23, pA420
[3]  
JOHNSON WJ, 1972, MAYO CLIN PROC, V47, P21
[4]  
MENDESMOURAO J, 1975, BIOCHEM J, V146, P457
[5]  
MITCH W, 1977, CLIN NEPHROL, V8, P341
[6]   EFFECTS OF ORAL NEOMYCIN AND KANAMYCIN IN CHRONIC UREMIC PATIENTS .1. UREA METABOLISM [J].
MITCH, WE ;
LIETMAN, PS ;
WALSER, M .
KIDNEY INTERNATIONAL, 1977, 11 (02) :116-122
[7]   UTILIZATION OF CALCIUM L-PHENYLLACTATE AS A SUBSTITUTE FOR PHENYLALANINE BY UREMIC PATIENTS [J].
MITCH, WE ;
WALSER, M .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (09) :1041-1046
[8]  
ODESSEY R, 1974, J BIOL CHEM, V249, P7623
[9]  
RICHARDS P, 1971, LANCET, V2, P128
[10]  
RICHARDS P, 1967, LANCET, V2, P845